GSKGLAXF
13F holders, Q3 2024 (September 30)2holders
1new positions
1sold out
$20.34avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding GSK PLC (GLAXF) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 1 sold out. The largest holders were Aristotle Capital Management, LLC ($70.2M) and Eagle Bay Advisors LLC ($62K).
- Company
- GSK PLC
- Filed as
- GSK (GLAXD) (Q3 2024)
- CUSIP
- G3910J179
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $62K |
| Exits | 1 | $3.2M |
All 13F filers, Q2 2024 → Q3 2024: 87,820 shares bought and 163,308 shares sold, net −75,488 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Aristotle Capital Management, LLC | 0.13% | Add +2.5% | 3,451,869 | $70.2M |
| Eagle Bay Advisors LLC | 0.02% | New | 3,060 | $62K |
"% of holder's portfolio" is GLAXF's weight in each manager's 13F, not the share of GSK PLC the manager owns.